Both in Pharmaceuticals
ADARx Pharmaceuticals vs Precigen
Over the past year ADRX returned −22.9% and PGEN returned −39.9%; their daily moves had a correlation of 0.35.
ADRX −22.9% PGEN −39.9%Growth of $1, one year, split-adjusted
| Metric | ADRX | PGEN |
|---|---|---|
| Price | $14.91 | $4.66 |
| Market cap | $1.59B | $1.67B |
| Today | +12.11% | −1.27% |
| 1 month | −16.4% | −36.6% |
| 6 months | — | +1.3% |
| Year to date | — | +11.5% |
| 1 year | — | +17.7% |
| Revenue growth (YoY) | — | +2437.6% |
| Gross margin | — | 91.2% |
| Net margin | — | 48.2% |
| P/E (TTM) | — | 68.5× |
| Price / sales | — | 10.6× |
| Net cash | — | -$48.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 92.8% |
| Short % of float | 3.4% | 26.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).